Health
Arthritis drug Tocilizumab reduces severe Covid mortality: study – Bangkok Post
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts…
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts welcomed as an “exciting” development.
The Britain-based RECOVERY research programme investigating Covid-19 treatments said their findings could have a significant effect on hospital survival rates during the pandemic.
The study included more than 2,000 patients who received the drug intravenously compared with nearly 3,000 who were given…
-
Noosa News24 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General23 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General20 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General13 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore